Table 3.
Crude and Standardized 5-Year Cumulative Incidence Estimates of Any Cancer, Accounting for Competing Risk of Death
| Crude | Standardizeda | |
|---|---|---|
| Age at dialysis initiation | ||
| 18-44 y | 3.91% (3.70%-4.11%) | 3.81% (3.55%-4.06%) |
| 45-64 y | 7.83% (7.65%-8.00%) | 8.07% (7.89%-8.25%) |
| ≥65 y | 11.17% (11.05%-11.29%) | 11.28% (11.15%-11.42%) |
| Sex | ||
| Male | 10.65% (10.53%-10.77%) | 10.93% (10.80%-11.05%) |
| Female | 8.27% (8.14%-8.40%) | 8.20% (8.06%-8.33%) |
| Race | ||
| White | 9.75% (9.62%-9.87%) | 9.36% (9.23%-9.48%) |
| Nonwhite | 9.05% (8.91%-9.19%) | 9.79% (9.57%-10.00%) |
| Ethnicity | ||
| Hispanic | 7.17% (6.92%-7.41%) | 8.54% (7.81%-9.27%) |
| Non-Hispanic | 9.83% (9.73%-9.93%) | 9.65% (9.55%-9.76%) |
| Reported cause of ESRD | ||
| Diabetes | 8.14% (8.02%-8.26%) | 8.30% (8.18%-8.42%) |
| Hypertension | 10.78% (10.60%-10.97%) | 10.39% (10.19%-10.59%) |
| Glomerulonephritis | 10.52% (10.18%-10.87%) | 12.01% (11.59%-12.43%) |
| Other | 11.36% (11.05%-11.67%) | 11.54% (11.20%-11.89%) |
| Calendar period of dialysis initiation | ||
| 1995-2002 | 9.26% (9.15%-9.37%) | 9.14% (9.02%-9.25%) |
| 2003-2010 | 9.65% (9.51%-9.79%) | 9.75% (9.60%-9.89%) |
| History of kidney transplant evaluation | ||
| No | 8.90% (8.79%-9.00%) | 8.72% (8.62%-8.82%) |
| Yes | 10.93% (10.74%-11.12%) | 11.67% (11.46%-11.88%) |
Note: Values are given as 5-year cumulative incidence (95% confidence interval).
Abbreviation: ESRD, end-stage renal disease.
a
Standardized cumulative incidence estimates account for case-mix characteristics (age at dialysis therapy initiation, sex, race, ethnicity, primary cause of ESRD, and year of dialysis therapy initiation) measured at baseline using inverse-probability weights.